BTBD7 Antikörper
Kurzübersicht für BTBD7 Antikörper (ABIN7227528)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Rabbit Anti-BTBD7 Polyclonal Antibody
-
Spezifität
- The antibody detects endogenous levels of BTBD7 protein
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from part region of human BTBD7 protein
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- BTBD7 (BTB (POZ) Domain Containing 7 (BTBD7))
-
Andere Bezeichnung
- BTBD7
-
Hintergrund
- BTB/POZ domain-containing protein 7Acts as a mediator of epithelial dynamics and organ branching by promoting cleft progression. Induced following accumulation of fibronectin in forming clefts, leading to local expression of the cell-scattering SNAIL2 and suppression of E-cadherin levels, thereby altering cell morphology and reducing cell-cell adhesion. This stimulates cell separation at the base of forming clefts by local, dynamic intercellular gap formation and promotes cleft progression (By similarity).
-
Molekulargewicht
- 124kD
-
Gen-ID
- 55727
-
UniProt
- Q9P203
Target
-